18th May 2021  Content supplied by: various sources as indicated

Latest Updates on COVID-19 Testing - Kits, Products, Services, Instrumentation - 18 May 2021


Zero-Contact Medical Station for Safe and Rapid PCR COVID-19 Testing

Zero-Contact Medical Station for Safe and Rapid PCR COVID-19 Testing

Brain Navi Biotechnology Co., Ltd has launched a “zero-contact” medical station in hospitals across Taiwan that fully protects medical staff and patients from the cross-infection of “highly contagious diseases,” including COVID-19.
Find Out More

 

Point-of-Care Rapid Flu and SARS-CoV-2/COVID-19 Antigen Test Receives FDA-EUA

Point-of-Care Rapid Flu and SARS-CoV-2/COVID-19 Antigen Test Receives FDA-EUA

The BD Veritor™ System for the rapid detection of SARS-CoV-2 and Flu A+B has received FDA-EUA and will be launched this summer for the 2021-2022 flu season. The test runs on the handheld BD Veritor™ Plus System and returns a result in about 15 minutes.
Find Out More

 

CRISPR Licensing Cuts To The Chase in Defeating COVID-19 Around the World

CRISPR Licensing Cuts To The Chase in Defeating COVID-19 Around the World

The 221b Foundation, established by Sherlock Biosciences, has announced it has granted several organizations a license to develop and distribute their own COVID-19 tests based on proprietary SHERLOCK technology, with the technology now been used in several continents. 
Find Out More

 

Centre of Excellence Expands to Double its Lateral-flow Membrane Output for Rapid Tests

Centre of Excellence Expands to Double its Lateral-flow Membrane Output for Rapid Tests

Merck is expanding its lateral flow membrane manufacturing site in response to global demand for COVID-19 tests. The lateral flow membrane is the key component in rapid diagnostic antigen tests, typically used in tests for infectious diseases like dengue fever, ebola and malaria, and COVID-19.
Find Out More

 

Flu and COVID-19 Vaccine Combo in Pipeline

Flu and COVID-19 Vaccine Combo in Pipeline

Novavax has announced positive preclinical data for their combination influenza and COVID-19 vaccine candidate. The combination vaccine elicited robust responses to both influenza A and B and protected against the SARS-CoV-2 virus.
Find Out More


 

    

Tags:

Date Published: 18th May 2021